Stock SNPX SYNAPTOGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Synaptogenix, Inc.

Equities

SNPX

US87167T3005

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-16 pm EDT 		5-day change 1st Jan Change
4.44 USD +0.23% Intraday chart for Synaptogenix, Inc. -1.33% -34.68%
Jul. 11 Maxim Upgrades Synaptogenix to Buy From Hold, Price Target is $14 MT
Jun. 26 Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis CI
6.QCtUPR41p-WMU1TQnbPpugUhS6gOXlxCw5-Yd-h0X-w.OAY8bHp0343rAW3m9MfezFxTEcpoBi17id38D4cubaQBcWZzJnTNh-sLDQ~20eec0c905a0f16856cee0f3c49eec03
  1. Stock Market
  2. Equities
  3. SNPX Stock
  4. Charts Synaptogenix, Inc.
  5. News Chart